43 results
8-K
EX-99.1
FBIO
Fortress Biotech Inc
15 May 24
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
4:20pm
. The study will also evaluate whether this intervention might reduce chronic inflammation and immune activation, as compared to placebo, and thus, potentially
8-K
EX-99.1
FBIO
Fortress Biotech Inc
15 May 23
Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
5:05pm
lymphomas (“B-NHL”) and chronic lymphocytic leukemia (“CLL”), throughout the year. Dotinurad for the treatment of gout and Triplex for the treatment
8-K
EX-99.1
sz1n2egq94f b0jd6
30 Mar 23
Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights
5:28pm
8-K
EX-99.1
x8zmg4x
14 Nov 22
Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:02pm
8-K
EX-99.1
mu82w8mh
11 Aug 22
Fortress Biotech Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
4:46pm
8-K
EX-99.1
jfmfsur9p3xgjmj0x
12 May 22
Fortress Biotech Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:16pm
8-K
EX-99.1
dko7j3j
28 Mar 22
Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
8:16am
8-K
EX-99.1
5bc2hd3v9to5y4subvu
15 Nov 21
Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
4:15pm
8-K
EX-99.1
xtad70cc9 uuf9jj85
16 Aug 21
Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights
4:08pm
8-K
EX-99.1
ka1lmeiu4
17 May 21
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
4:21pm